Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 18.00 68,169 08:00:00
Bid Price Offer Price High Price Low Price Open Price
17.00 19.00 18.00 18.00 18.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -13.62 -18.82 21
Last Trade Time Trade Type Trade Size Trade Price Currency
11:26:27 O 2,668 18.40 GBX

C4x Discovery (C4XD) Latest News

More C4x Discovery News
C4x Discovery Takeover Rumours

C4x Discovery (C4XD) Discussions and Chat

C4x Discovery Forums and Chat

Date Time Title Posts
05/8/202006:39C4X Discovery Holdings plc1,842

Add a New Thread

C4x Discovery (C4XD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all C4x Discovery trades in real-time

C4x Discovery (C4XD) Top Chat Posts

C4x Discovery Daily Update: C4x Discovery Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker C4XD. The last closing price for C4x Discovery was 18p.
C4x Discovery Holdings Plc has a 4 week average price of 13.50p and a 12 week average price of 13.25p.
The 1 year high share price is 47p while the 1 year low share price is currently 8p.
There are currently 119,203,144 shares in issue and the average daily traded volume is 216,782 shares. The market capitalisation of C4x Discovery Holdings Plc is £21,456,565.92.
davemac3: Repricing the options probably means news is not imminent. It would look bad if they announced news that doubled the share price soon after reducing the option price.
siennadelekat21: Just wondering if it would have been better to have those options set at a higher price than 16p - say something more like 30p?Would that not have given the board more of an incentive to drive that share price higher?Sienna
davemac3: why buy C4X now? they don't know the orexin compound will work. Not much value in C4X for Indivior until Phase 2. PS an odd share price response to the INDV news.
the stigologist: Put phone call into Company, NOMAD and FCA demanding a 'We know no reason for share price movement' RNS People sharing #FakeNews / lies need turning over and made examples of. Conmen.
alloa2003: I am not asking for my hand to be held lol All I am saying is that if you look back at his interviews a year or so ago, he was much more upbeat about a timetable for new deals but that seems to have faded in his more recent interviews. I have no issue with companies keeping quiet while they work on deals but the share price is now below the placing price and has halved from the day of the discounted fund raising. I would have thought if things are progressing then a quick update would not go a miss :)
the stigologist: Do you mind telling your share price this Clive ? Jan 17 Another successful @JPMorgan Healthcare Conference kicking off the start to what will be a great year. Looking forward to continuing our progress in 2020! Jan 7 Commenting on today’s preliminary results, Clive Dix, our CEO, commented “With the business in a strong position, we are excited by our future prospects as we focus on building our pioneering Drug Discovery company towards sustainability.̶1;
the stigologist: Computational Biology sector should be on fire today after ETX SP Angel... "e-therapeutics (ETX.L): Board restructuring Share Price: 3.9p; Market Capitalisation: £10.5m * e-therapeutics, a computational drug discovery business, announced board restructuring and a £1.6m placing. * Ali Mortazavi has been appointed Executive Chairman, with the current Non-Executive Chairman, CEO and CFO departing the Company. * The Group also £1.6m placing at 3p/share with the funds to be used for general working capital purposes. The appointment of Mr Mortazavi, who was CEO of Silence Therapeutics (SLN.L), for six years, marks an opportunity to turnaround the business, which was affected last year by the Woodford overhang. The current Group strategy is to strike revenue or cash generating collaborations through its network-driven drug discovery (NDD) and Genome Associated Interaction Networks (GAINs) platforms and has collaborations with big pharma, including Novo Nordisk. Computer-based drug development is an attractive prospect for industry, as it could dramatically reduce risk, cost and time by generating data in silicon rather than in the lab."
skyracer: Existing shareholders who took part in the placing at 90p, and the Directors, who insisted on such a crushing discount at 15p may have shot themselves in the foot. They have sucked all confidence from the share price and only a very good deal may now help the share price recover. It might have been better if they had restrained their greed and agreed to a confidence-boosting placing at say 40p. How are they going to feel if the general public now get the opportunity to buy shares sub 10p, not so clever, it will be their fault for trashing the share price to 15p in the first place.
tickboo: I'd say the share price more often than not goes down to the discounted raise price. It doesn't matter whether it's 0.6p, 2p or £1 it's the percentage discount that matters so you're way off there. If XZ has a share price of £100 and the discount was £1 so £99 raise is that not better than if the share price was 10p and a discount of 2.5p son7.5p?! Deary me.
alloa2003: I do chuckle sometimes as once this share starts to move, ahead or after the next payment/deal, every trader and their dog will want a slice. They are prepared to pay a much higher price just to buy on momentum rather than take advantage of a lack of interest and a drifting share price. I will repeat myself here but I much prefer a management who get on with the job, and let the share price look after itself, rather than throwing out irrelevant announcements just to remind people they are there and support the share price.
C4x Discovery share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
C4x Discov..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200805 14:12:43